{"schema_version":"secwatch.filing_event.v1","accession":"0001842952-22-000050","form_type":"8-K","ticker":"CNTX","cik":"0001842952","company_name":"Context Therapeutics Inc.","filed_at":"2022-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.775349+00:00","generated_at":"2026-06-25T04:52:48.405590+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Context Therapeutics shareholders ratify CohnReznick as auditor for FY 2022","bullets":["Annual meeting held June 2, 2022; quorum of 9,161,941 shares (57.38%) present.","Proposal 1: Ratification of CohnReznick LLP as independent auditor for 2022.","Votes: 9,144,524 For, 8,877 Against, 8,540 Abstentions; no broker non-votes.","Auditor appointment for year ending December 31, 2022 approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001842952-22-000050","json":"https://secwatch.observer/filing/0001842952-22-000050.json","markdown":"https://secwatch.observer/filing/0001842952-22-000050.md","text":"https://secwatch.observer/filing/0001842952-22-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842952/000184295222000050/0001842952-22-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842952/000184295222000050/cntx-20220602.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:52:48.405590+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}